Eliel Bayever, MD, Pediatric Hematology & Oncology, Monmouth Junction, NJ

ElielBayeverMDMRCP

Pediatric Hematology & Oncology Monmouth Junction, NJ

Pediatric Hematologic Oncology, Pediatric Solid Tumor Oncology

Chief Medical Officer, Elucida Oncology, Inc.

Dr. Bayever is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Bayever's full profile

Already have an account?

Education & Training

  • University of the Witwatersrand
    University of the WitwatersrandClass of 1973

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1992 - 2019

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Quest Announces That OncoQuest Pharmaceuticals Inc. Doses First Patient in Phase 3 Clinical Trial, FLORA-5, of Company's Lead Investigational Drug, Oregovomab, in Frontline Ovarian Cancer and Appoints Dr. Sunil Gupta as Chief Medical Officer
    Quest Announces That OncoQuest Pharmaceuticals Inc. Doses First Patient in Phase 3 Clinical Trial, FLORA-5, of Company's Lead Investigational Drug, Oregovomab, in Frontline Ovarian Cancer and Appoints Dr. Sunil Gupta as Chief Medical OfficerNovember 9th, 2020
  • OncoQuest Lays the Groundwork for Commencement of Phase 3 Study in Frontline Ovarian Cancer
    OncoQuest Lays the Groundwork for Commencement of Phase 3 Study in Frontline Ovarian CancerFebruary 15th, 2019
  • Merrimack and Baxalta Announce Enrollment of First Patient in Phase 2 Study of ONIVYDE™ (Irinotecan Liposome Injection) in Previously Untreated Front-Line Metastatic Pancreatic Cancer
    Merrimack and Baxalta Announce Enrollment of First Patient in Phase 2 Study of ONIVYDE™ (Irinotecan Liposome Injection) in Previously Untreated Front-Line Metastatic Pancreatic CancerOctober 27th, 2015
  • Join now to see all